NCT07149220 2025-08-29
FMS
Ohio State University
Phase 1 Recruiting
Clinical Trials
5 trialsNCT05505539 2022-09-22
OL_5FU
University of California, San Francisco
Phase 1 Withdrawn
NCT03939364 2021-10-19
This Study is to Evaluate the Safety and Pharmacokinetics of SBS-101 in Patients With Oral Premalignant Lesions
Skyline Biosciences
Phase 1 Withdrawn
NCT00571558 2014-10-09
Photodynamic Therapy Using Aminolevulinic Acid in Treating Patients With Oral Leukoplakia
National Cancer Institute (NCI)
Phase 1 Terminated
NCT01238185 2013-08-12
Aspirin Mouthwash in Treating Patients With Oral Leukoplakia
National Cancer Institute (NCI)
Phase 1 Completed